Related Experiment Video
Updated: May 22, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Prevalence of diabetes mellitus in biopsy-positive giant cell arteritis
Jared L Matthews1, David N Gilbert, Bradley K Farris
1University of Oklahoma College of Medicine, Oklahoma City, OK, USA. JMatthews2@med.miami.edu
Background:
We tested the hypothesis that patients with diabetes mellitus (DM) develop biopsy-positive giant cell arteritis (GCA) significantly less frequently than nondiabetic patients.
Methods:
We compared the prevalence of DM in patients with positive temporal artery biopsy (TAB) with that in patients with negative TAB via a retrospective study of 215 patients who underwent TAB. Patients were classified as having biopsy-positive GCA if microscopic examination disclosed active or healed arteritis. Patients were classified as having DM if they had a diagnosis of diabetes in their medical history or were taking oral hypoglycemic medications and/or insulin at or before the time of biopsy. In addition, we performed a meta-analysis of 8 previously published articles with a total of 1,401 additional biopsy-proven cases of GCA in patients whose status was recorded as diabetic or nondiabetic.
Results:
Of 44 cases with biopsy-positive GCA in our patient cohort, only 4 (9.1%) were diabetic at or before the time of biopsy. Of 171 patients with negative TAB, 61 (35.7%) had DM (P = 0.0006). The prevalence of DM among recorded cases of biopsy-positive GCA ranged from 0% to 13.8% in the 8 studies included in our meta-analysis, with a combined frequency of 89 diabetic patients in a total of 1,401 cases (6.35%).
Conclusion:
The low frequency of a positive TAB in diabetic GCA suspects should be considered when formulating an index of suspicion in the evaluation of patients with possible GCA. More research is needed to delineate the nature of the interaction between DM and GCA.
Insights
Patients with diabetes mellitus (DM) are less likely to have biopsy-positive giant cell arteritis (GCA). This finding suggests reconsidering diagnostic suspicion in diabetic patients with potential GCA.
Area of Science:
- Rheumatology
- Endocrinology
- Pathology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis.
- The association between diabetes mellitus (DM) and GCA is not well understood.
- This study investigates the prevalence of DM in biopsy-positive GCA cases.
Purpose of the Study:
- To test the hypothesis that patients with DM develop biopsy-positive GCA less frequently than nondiabetic patients.
- To compare DM prevalence in patients with positive vs. negative temporal artery biopsies (TAB).
- To conduct a meta-analysis of existing literature on DM and biopsy-proven GCA.
Main Methods:
- Retrospective study of 215 patients undergoing TAB.
- Classification of biopsy-positive GCA based on microscopic examination.
- Definition of DM based on medical history or medication use.
- Meta-analysis of 8 published studies including 1,401 additional GCA cases.
Main Results:
- In the study cohort, only 9.1% of biopsy-positive GCA cases had DM.
- A significantly lower prevalence of DM was observed in biopsy-positive GCA patients compared to those with negative TAB (9.1% vs. 35.7%, P = 0.0006).
- Meta-analysis revealed a combined DM prevalence of 6.35% in 1,401 biopsy-proven GCA cases.
Conclusions:
- The low frequency of biopsy-positive GCA in diabetic patients warrants consideration when evaluating suspected GCA.
- Further research is necessary to elucidate the interaction between DM and GCA.
- Diagnostic suspicion for GCA may need adjustment in diabetic individuals.
More Related Videos
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Nephropathy
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
Type I Diabetes III: Clinical Manifestations

